de Magalhaes, J. P. How ageing processes influence cancer. Nat. Rev. Cancer 13, 357–365 (2013).

Article  Google Scholar 

Laconi, E., Marongiu, F. & DeGregori, J. Cancer as a disease of old age: changing mutational and microenvironmental landscapes. Br. J. Cancer 122, 943–952 (2020).

Article  Google Scholar 

Van Herck, Y. et al. Is cancer biology different in older patients? Lancet Healthy Longev. 2, E663–E677 (2021).

Article  Google Scholar 

Sceneay, J. et al. Interferon signaling is diminished with age and is associated with immune checkpoint blockade efficacy in triple-negative breast cancer. Cancer Discov. 9, 1208–1227 (2019).

Article  CAS  Google Scholar 

Kaur, A. et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature 532, 250–254 (2016).

Article  CAS  Google Scholar 

Kim, B. Y., Rutka, J. T. & Chan, W. C. Nanomedicine. N. Engl. J. Med. 363, 2434–2443 (2010).

Article  CAS  Google Scholar 

Jiang, W. et al. Designing nanomedicine for immuno-oncology. Nat. Biomed. Eng 1, 0029 (2017).

Article  CAS  Google Scholar 

Rodriguez, P. L. et al. Minimal ‘self’ peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science 339, 971–975 (2013).

Article  CAS  Google Scholar 

Parodi, A. et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat. Nanotechnol. 8, 61–68 (2013).

Article  CAS  Google Scholar 

Gradishar, W. J. et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J. Clin. Oncol. 23, 7794–7803 (2005).

Article  CAS  Google Scholar 

Barenholz, Y. Doxil®—the first FDA-approved nano-drug: lessons learned. J. Control. Release 160, 117–134 (2012).

Article  CAS  Google Scholar 

Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021).

Article  CAS  Google Scholar 

Blanco, E., Shen, H. & Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941–951 (2015).

Article  CAS  Google Scholar 

Ngo, W. et al. Identifying cell receptors for the nanoparticle protein corona using genome screens. Nat. Chem. Biol. 18, 1023–1031 (2022).

Article  CAS  Google Scholar 

Boehnke, N. et al. Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery. Science 377, eabm5551 (2022).

Article  CAS  Google Scholar 

Dobrowolski, C. et al. Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery. Nat. Nanotechnol. 17, 871–879 (2022).

Article  CAS  Google Scholar 

Jiang, W., Wang, Y., Wargo, J. A., Lang, F. F. & Kim, B. Y. S. Considerations for designing preclinical cancer immune nanomedicine studies. Nat. Nanotechnol. 16, 6–15 (2021).

Article  Google Scholar 

Ouyang, B. et al. The dose threshold for nanoparticle tumour delivery. Nat. Mater. 19, 1362–1371 (2020).

Article  CAS  Google Scholar 

Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 1–12 (2016).

Article  Google Scholar 

Chen, Y. et al. Therapeutic remodeling of the tumor microenvironment enhances nanoparticle delivery. Adv. Sci. (Weinh.) 6, 1802070 (2019).

Google Scholar 

Pili, R. et al. Altered angiogenesis underlying age-dependent changes in tumor growth. J. Natl Cancer Inst. 86, 1303–1314 (1994).

Article  CAS  Google Scholar 

Marinho, A., Soares, R., Ferro, J., Lacerda, M. & Schmitt, F. C. Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Pathol. Res. Pract. 193, 267–273 (1997).

Article  CAS  Google Scholar 

Ouyang, B. et al. Impact of tumor barriers on nanoparticle delivery to macrophages. Mol. Pharm. 19, 1917–1925 (2022).

Article  CAS  Google Scholar 

Grolleau, A., Misek, D. E., Kuick, R., Hanash, S. & Mule, J. J. Inducible expression of macrophage receptor Marco by dendritic cells following phagocytic uptake of dead cells uncovered by oligonucleotide arrays. J. Immunol. 171, 2879–2888 (2003).

Article  CAS  Google Scholar 

Hamilton, R. F. Jr., Thakur, S. A., Mayfair, J. K. & Holian, A. MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice. J. Biol. Chem. 281, 34218–34226 (2006).

Article  CAS  Google Scholar 

Park, J. et al. Intravascular innate immune cells reprogrammed via intravenous nanoparticles to promote functional recovery after spinal cord injury. Proc. Natl Acad. Sci. USA 116, 14947–14954 (2019).

Article  CAS  Google Scholar 

Pikkarainen, T., Brannstrom, A. & Tryggvason, K. Expression of macrophage MARCO receptor induces formation of dendritic plasma membrane processes. J. Biol. Chem. 274, 10975–10982 (1999).

Article  CAS  Google Scholar 

Hirano, S., Fujitani, Y., Furuyama, A. & Kanno, S. Macrophage receptor with collagenous structure (MARCO) is a dynamic adhesive molecule that enhances uptake of carbon nanotubes by CHO-K1 cells. Toxicol. Appl Pharm. 259, 96–103 (2012).

Article  CAS  Google Scholar 

van der Laan, L. J. et al. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J. Immunol. 162, 939–947 (1999).

Article  Google Scholar 

Arredouani, M. S. et al. MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. J. Immunol. 175, 6058–6064 (2005).

Article  CAS  Google Scholar 

Li, Z. et al. Aging-impaired filamentous actin polymerization signaling reduces alveolar macrophage phagocytosis of bacteria. J. Immunol. 199, 3176–3186 (2017).

Article  CAS  Google Scholar 

Ojala, J. R., Pikkarainen, T., Tuuttila, A., Sandalova, T. & Tryggvason, K. Crystal structure of the cysteine-rich domain of scavenger receptor MARCO reveals the presence of a basic and an acidic cluster that both contribute to ligand recognition. J. Biol. Chem. 282, 16654–16666 (2007).

Article  CAS  Google Scholar 

Novakowski, K. E. et al. A naturally occurring transcript variant of MARCO reveals the SRCR domain is critical for function. Immunol. Cell Biol. 94, 646–655 (2016).

Article  CAS  Google Scholar 

Brannstrom, A., Sankala, M., Tryggvason, K. & Pikkarainen, T. Arginine residues in domain V have a central role for bacteria-binding activity of macrophage scavenger receptor MARCO. Biochem. Biophys. Res. Commun. 290, 1462–1469 (2002).

Article  Google Scholar 

Wang, Y. et al. Mutant LKB1 confers enhanced radiosensitization in combination with trametinib in KRAS-mutant non-small cell lung cancer. Clin. Cancer Res. 24, 5744–5756 (2018).

Article  CAS  Google Scholar 

Guilliams, M. et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell 185, 379–396 (2022).

Article  CAS  Google Scholar 

Tabula Sapiens Consortium. The Tabula Sapiens: a multiple-organ, single-cell transcriptomic atlas of humans. Science 376, eabl4896 (2022).

Article  Google Scholar 

Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).

Article  Google Scholar